Organometallic Compound for OLED Light Emission Efficiency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current organic light-emitting devices and diagnostic compositions lack optimal performance in terms of light emission efficiency and biological sensing capabilities due to limitations in the design and functionality of their organic layers.
Innovation Solution
The development of organometallic compounds represented by Formula 1, which are integrated into the organic layers of light-emitting devices and diagnostic compositions, enhancing light emission properties and biological sensing capabilities by utilizing specific transition metals and ligands that improve exciton formation and recombination processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Use of energy by moving object
If conventional organic compounds are used in the emission layer, then the device structure is simple, but the light emission efficiency is insufficient
Solution Approach 1:
The patent employs composite organometallic compounds combining organic ligands with metal centers (Ir, Pt, Os, Rh, Ru) to achieve superior light emission efficiency. The composite structure integrates the advantages of organic materials (tunability, processability) with metal centers (high quantum yield, phosphorescence), resolving the contradiction between emission efficiency and structural complexity.
Solution Approach 2:
The patent systematically varies key parameters including metal center selection (different rows of transition metals), ligand types (Formula 1-1 and Formula 1-2 structures), and substituent groups (R1-R44) to optimize light emission efficiency. This parameter optimization approach enables fine-tuning of photophysical properties while managing structural complexity.
2Reliability
If standard organic layers are used, then the device is easy to manufacture, but the biological sensing capability is limited
Solution Approach 1:
The patent introduces specific functional groups and ligand structures (Formula 1-1 and Formula 1-2) with tailored electronic and steric properties to enhance biological sensing capability at specific sites within the molecule. This local optimization of molecular structure enables selective biological interactions while maintaining overall manufacturability through established organometallic synthesis routes.
3Power
If conventional ligands are used in organometallic compounds, then the synthesis is straightforward, but the exciton formation and recombination processes are not optimized
Solution Approach 1:
The patent optimizes ligand parameters including denticity (bidentate vs. other coordination modes), chelate ring size, and electronic properties (electron-donating/withdrawing groups R1-R44) to enhance exciton formation and recombination efficiency. The specific Formula 1-1 and Formula 1-2 ligand structures are designed to facilitate efficient spin-orbit coupling and exciton management, directly improving power conversion and emission characteristics.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The incorporation of these organometallic compounds into organic light-emitting devices and diagnostic compositions leads to improved light emission efficiency and enhanced biological sensing capabilities, addressing existing limitations and offering superior performance in both applications.
Implementation Method 1
The holes and the electrons recombine in the emission layer to produce excitons. These excitons transit from an excited state to a ground state to thereby generate light.
Data Source
AI summary
Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound. <Formula 1> M1(L11)n11(L12)n12 wherein L11 in Formula 1 is a ligand represented by Formula 1-1, and the descriptions of other substituents are the same as described in the detailed description of the present application: